Placebo design, reporting compliance, and methodological problems in randomized, placebo-controlled trials of Chinese herbal medicine: A cross-sectional study

医学 替代医学 临床试验 安慰剂 传统医学 报告审判综合标准 随机对照试验 中医药 梅德林 研究设计 家庭医学 质量(理念) 科学网 数据提取 描述性统计 荟萃分析 物理疗法 透明度(行为) 系统回顾 重症监护医学 第N部分,共1次审判 临床研究设计 相对风险
作者
Jingyi Yu,Sai Jiang,Yuxing Wang,Hejing Pan,Hui Liu,Xuanlin Li,Yuehua Chen,Chengping Wen
出处
期刊:Pharmacological Research [Elsevier BV]
卷期号:229: 108244-108244
标识
DOI:10.1016/j.phrs.2026.108244
摘要

This cross-sectional study aimed to characterize the design, application, and reporting standards of Chinese herbal medicine placebos (CHM-placebos) in randomized controlled trials (RCTs) published between 2018 and 2025. We searched the Web of Science database for RCTs involving Chinese herbal medicine (CHM) and matching placebos published from January 2018 to September 2025. Methodological quality was assessed using Risk of Bias Instrument for Use in Systematic reviews for Randomized Controlled trials (ROBUST-RCT). Reporting compliance was evaluated according to the Consolidated Standards of Reporting Trials (CONSORT) Extension for Chinese Herbal Medicine Formulas (CONSORT-CHM). Descriptive statistics summarized features of CHM-placebos’ design. A total of 136 trials were included. Methodological assessment revealed that “Allocation concealment” had the highest risk (definitely high risk: 4%, probably high risk: 19%). Reporting compliance with CONSORT-CHM placebo-specific items was low, only 16 trials (11.76%) fully reported the name and amount of each ingredient, 6 trials (4.41%) trials reported quality control and safety assessments, and 9 trials (6.62%) provided complete production information. Manufacturers’ information was reported in 90 trials (66.18%). 33 trials (24.26%) reported that their CHM-placebos contained traditional Chinese medicine ingredients, with two trials using placebos composed entirely of TCM. Deficiencies persist in the CHM-placebos’ design and reporting, especially regarding compositional transparency and quality verification. The use of CHM-placebos containing TCM ingredients challenges the fundamental principle of pharmacological inertness. • A great amount of CHM-placebos contain TCM ingredient, even up to 100%. • Randomized placebo-controlled trials of CHM have low compliance to the CONSORT-CHM. • The information of CHM-placebos are reported seriously incompletely, especially for quality control, safety assessment and production information. • The information of CHM-placebos in trials with cooperation between nations, multi-center design and high impact factors have more sufficient report.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
123wsq发布了新的文献求助10
刚刚
刘某完成签到,获得积分10
1秒前
眨眼完成签到,获得积分10
2秒前
传奇3的应助被cc2004bj采纳,获得50
2秒前
4秒前
5秒前
青年才俊发布了新的文献求助30
7秒前
7秒前
woo发布了新的文献求助10
8秒前
sunziyi发布了新的文献求助10
8秒前
bai完成签到 ,获得积分10
8秒前
9秒前
9秒前
277发布了新的文献求助10
10秒前
Wu完成签到,获得积分20
11秒前
12秒前
薯片完成签到 ,获得积分10
13秒前
陆程文完成签到,获得积分10
14秒前
14秒前
qingtian发布了新的文献求助10
14秒前
ledawang完成签到,获得积分10
15秒前
123wsq完成签到,获得积分20
16秒前
16秒前
16秒前
脑洞疼的应助被sunziyi采纳,获得10
16秒前
张子豪完成签到,获得积分10
16秒前
科研小白发布了新的文献求助10
17秒前
17秒前
sure完成签到 ,获得积分10
18秒前
若水完成签到,获得积分10
18秒前
19秒前
19秒前
淡定的飞阳完成签到 ,获得积分10
19秒前
19秒前
沐婉子完成签到,获得积分10
20秒前
马登完成签到,获得积分10
21秒前
迅速完成签到,获得积分20
21秒前
woo完成签到,获得积分10
21秒前
21秒前
成就书芹发布了新的文献求助10
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181658
求助须知:如何正确求助?哪些是违规求助? 9571454
关于积分的说明 21818081
捐赠科研通 7777987
什么是DOI,文献DOI怎么找? 3433508
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479568